November 11, 2008
NEP Brings Three To Advisory Board
By Matthew L. Brown
Gardner's New England Peptide LLC has named three specialists to its newly formed scientific advisory board.
Vincent Bille, the founder of Brussels-based Marble Pharma Consulting, Tomi Sawyer, chief scientific officer at Cambridge-based Aileron Therapeutics and Ved Srivastava, associate director of discovery research at Amylin Pharmaceuticals in San Diego have all agreed to join the board, the company said.
The board was formed to formulate business strategy, strengthen product development efforts and improve the efficiency of New England Peptide's peptide synthesis processes.
New England Peptide designs and manufactures custom peptides and antibodies for the drug and vaccine discovery industry.
WBJ Web Partners
Most Recent
Most Recent
0 Comments